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Posttraumatic stress disorder (PTSD) symptoms can result in functional impairment
among service members (SMs), even in those without a clinical diagnosis. The variability
in outcomes may be related to underlying catecholamine mechanisms. Individuals
with PTSD tend to have elevated basal catecholamine levels, though less is known
regarding catecholamine responses to trauma-related stimuli. We assessed whether
catecholamine responses to a virtual combat environment impact the relationship
between PTSD symptom clusters and elements of functioning. Eighty-seven clinically
healthy SMs, within 2 months after deployment to Iraq or Afghanistan, completed self-
report measures, viewed virtual-reality (VR) combat sequences, and had sequential
blood draws. Norepinephrine responses to VR combat exposure moderated the
relationship between avoidance symptoms and scales of functioning including physical
functioning, physical-role functioning, and vitality. Among those with high levels of
avoidance, norepinephrine change was inversely associated with functional status,
whereas a positive correlation was observed for those with low levels of avoidance. Our
findings represent a novel use of a virtual environment to display combat-related stimuli
to returning SMs to elucidate mind-body connections inherent in their responses. The
insight gained improves our understanding of post-deployment symptoms and quality of
life in SMs and may facilitate enhancements in treatment. Further research is needed to
validate these findings in other populations and to define the implications for treatment
effectiveness.
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Introduction
Symptoms of posttraumatic stress disorder (PTSD) are common in the aftermath of war, and
the recent wars in Iraq and Afghanistan are no exception (Veterans Health Administration, 2014).
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Exposure to traumatic experiences such as being attacked,
ambushed, or in an accident, or witnessing physical devasta-
tion during these campaigns has been associated with PTSD,
depressive symptoms, hazardous drinking, and relationship
stress, which persist for at least 9 months after returning home
(Cigrang et al., 2014). PTSD symptoms resulting from combat-
related events can impair quality of life and functional status
(e.g., degree of disability across domains of health and behav-
ior) among service members (SMs; Schnurr et al., 2009), includ-
ing those who are subthreshold, or lacking a suﬃcient num-
ber or distribution of symptoms to meet full criteria for PTSD
(Magruder et al., 2004; Grubaugh et al., 2005; Cukor et al., 2010).
PTSD symptom clusters include re-experiencing (e.g., intru-
sive memories and bad dreams), avoidance (e.g., avoidance of
trauma-related thoughts, feelings, activities, as well as a loss of
social connection, and interest in activities), and hyperarousal
(e.g., strong startle response, sleep problems, angry outbursts,
hypervigilance), with dysphoric mood recently added. While
PTSD is associated with poorer functional outcomes overall, this
relationship may vary according to particular symptom clus-
ters and domains of functional status. The intent of this report
is to explore the relationship between PTSD symptom clus-
ters and functional impairment through an assessment of blood
catecholamine responses to a combat-related virtual environ-
ment in a sample of U.S. military SMs recently returned from
deployment.
Posttraumatic stress disorder symptoms are multifaceted and
the number and intensity of symptoms can vary considerably
between individuals resulting in variable patterns of functional
impairment (Norrholm and Jovanovic, 2010). Previous studies
suggest the importance of examining PTSD symptom clus-
ters separately, rather than one amalgamated score. In studies
of veterans of the Iraq and Afghanistan wars, dysphoria has
been linked to a multitude of poor outcomes including men-
tal health function, problematic alcohol use, and greater psy-
chosocial, and work diﬃculties (Pietrzak et al., 2010), as well as
greater propensity to seek mental health care (Blais et al., 2014).
Re-experiencing symptoms have been positively associated with
alcohol use problems (Pietrzak et al., 2010), healthcare utilization
(Blais et al., 2014), reduced health functioning, and elevated bod-
ily pain (Asnaani et al., 2014); while avoidance was linked with
greater psychosocial diﬃculties (Pietrzak et al., 2010) and lower
healthcare utilization (Blais et al., 2014). Hyperarousal symptoms
have been independently associated with lower vitality and emo-
tional functioning (Asnaani et al., 2014). Though PTSD symp-
tom clusters have sometimes been associated with functional
deﬁcits, they are not invariably associated with impaired func-
tion, and psychophysiological factors may represent important
moderators.
The sympathetic nervous system stimulates the release of the
catecholamines epinephrine, norepinephrine, and dopamine to
mediate adaptive responses to acute stressors (Southwick et al.,
2002; Cahill and Alkire, 2003), but they are also linked with
long-term memory of events that induce strong emotions such
as fear (Soeter and Kindt, 2011). Though adaptive for acute
stress, chronic stress, and associated repetitive catecholamine-
system activation leads to damaging biopsychosocial outcomes
(Mead et al., 2010). In a community sample, individuals with
PTSD had higher 24-h levels of catecholamines compared to
both those without trauma exposure, as well as those exposed
to trauma who did not develop PTSD (Young and Breslau,
2004). In fact, those with trauma exposure who did not develop
PTSD actually had lower catecholamine levels than those with-
out trauma exposure (Young and Breslau, 2004), indicating a
potential mechanism for resilience. Though catecholamine lev-
els are related to PTSD symptomatology, research on cat-
echolamine responses to acute combat-related cues among
post-deployment SMs is limited. In a small study of veter-
ans with and without PTSD, those with PTSD had exaggerated
epinephrine and norepinephrine responses to combat-sounds
than those without PTSD (Liberzon et al., 1999). Recent tech-
nological advances make it possible to present salient combat-
related stimuli and monitor individualized psychophysiologi-
cal reactions, providing the potential to elucidate the com-
plexities of trauma-related symptomology and functioning out-
comes.
Virtual reality exposure therapy (VRET) has shown eﬃ-
cacy in the treatment of combat-related PTSD (Roy et al.,
2010; McLay et al., 2011; Reger et al., 2011; Goncalves et al., 2012;
McLay et al., 2014). A study conducted in U.S. veterans with
recent-onset combat-related PTSD found both that virtual reality
(VR) was acceptable to them, and that the psychological, physio-
logical, and behavioral responses it elicited were similar to those
they had experienced during deployment (Kramer et al., 2013).
However, there is relatively little in the medical literature regard-
ing the use of VR in PTSD assessment. Recently, one study exam-
ined responses to neutral computer-generated characters using
head-mounted display VR in participants who had experienced
a physical assault 4 weeks prior, which found that reactions to
the neutral stimuli predicted paranoia and PTSD 6 months later
(Freeman et al., 2014). We previously documented a relationship
between physiologic responses to combat-related VR scenarios
and PTSD symptoms (Roy et al., 2013; Costanzo et al., 2014), but
we believe that incorporation of catecholamine measurements in
the analysis can further improve our understanding of the impact
of exposure to virtual combat sequences. We therefore exam-
ine catecholamine levels (epinephrine, norepinephrine) before
and after exposure to virtual combat sequences in relation to
PTSD symptom clusters (e.g., re-experiencing, avoidance, hyper-
arousal) and multiple functional domains (e.g., mental health,
physical health, vitality). We hypothesize that catecholamine
responses to virtual combat sequences will positively correlate
with PTSD symptom clusters and that each will be inversely
correlated with functional status.
Materials and Method
Participants and Procedures
The present study was approved by the institutional review
boards at the Walter Reed National Military Medical Center,
Uniformed Services University of the Health Sciences, and the
National Institutes of Health, and adhered to the Declaration of
Helsinki. Clinically healthy SMs within 2 months of return from
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deployment to either Iraq or Afghanistan ﬁrst completed self-
report questionnaires, then viewed VR combat sequences, and
completed baseline and post-VR blood draws for catecholamines.
Participants viewed 3 sequential 2-min Virtual Iraq prescripted
sequences (Rizzo et al., 2010) on a computer screen, which were
separated by 30-s presentations of a blue square; the sequences,
respectively, depicted a ﬁrst person view at the gunner position of
a Humvee, within the cabin of a Humvee, and walking through
the streets of amiddle eastern city. The scenarios included smoke,
gunﬁre, explosions, and overhead aircraft.
Blood was drawn from each participant prior to 9:00 AM
(baseline), as well as immediately after exposure to the
three virtual combat sequences. Plasma samples were iso-
lated from whole blood in sodium heparin preserved col-
lection tubes with centrifugation for 10 min at room tem-
perature. Samples were stored at −70◦C, and all samples
were then run in a single batch. Following manufacturer’s
instructions, a commercially available enzyme immunoassay
was used to measure plasma catecholamine levels, including
epinephrine and norepinephrine. First, catecholamines were
extracted with a cis-diol-aﬃnity speciﬁc gel, followed by acety-
lation and enzymatic conversion. Then, the separate microtiter
plates bound with speciﬁc catecholamine antigen were pro-
cessed with a competitive enzyme linked immunosorbent assays.
Standards, controls, samples, and their respective antiserum
were incubated for 20 h, followed by washing with the auto-
mated plate washer to remove free antigen-antiserum com-
plexes. An anti-rabbit IgG-peroxidase conjugate using 3.3′,
5.5′ Tetramethylbenzidine (TMB) as the substrate detected
antibody, and a plate reader then detected absorbance at
450 nm. Next, sample and standard curve analysis was calcu-
lated. A non-linear regression, 4-parameter logistic curve ﬁtting
method calculated the standard curve and sample concentra-
tions (Molecular Devices Corporation, 2012). The equation used
to generate this curve ﬁt is: y = ((A − D) / (1 + (× /C) B)) + D.
Measures
Posttraumatic stress disorder symptom clusters were assessed
with the 17-item PTSD Checklist Military Version (PCL-M), for
which the total score may range from 17 to 85, with the var-
ious items measuring symptoms within each of the 3 clusters.
The PCL-M compares favorably with the gold-standard Clinician
Administered PTSD Scale (Forbes et al., 2001). Functional status
was assessed using the widely used and well-validated 36-item
Short Form Health Survey (SF-36; Ware and Sherbourne, 1992).
Epinephrine and norepinephrine values at baseline were sub-
tracted from values after VR so that “catecholamine responses”
represent the diﬀerence in values between the two time points.
Analyses
Demographic characteristics and biopsychosocial factors were
assessed by univariate analysis to obtain frequencies for cate-
gorical variables and means and standard deviations for con-
tinuous variables. We then examined the relationships between
PTSD symptom clusters, catecholamine responses, and func-
tional status subscales in a multivariate fashion with a series
of multiple linear regressions. A PCL-M cluster (centered) was
placed in Block 1 and a catecholamine response value (centered)
was placed in Block 2. To examine moderating eﬀects, the respec-
tive PCL-M cluster X catecholamine response interaction term
was placed in Block 3. To control for the risk of false positive
ﬁndings, we utilized an online False Discovery Rate calcula-
tor (http://sdmproject.com/utilities). All statistical analyses were
completed using IBM SPSS (version 22).
Results
Univariate and Bivariate Findings
Study participants (N = 87) were predominantly male (80%) and
self-identiﬁed as white (73%); all were either active or reserve
component SMs representing multiple military service branches.
On average, participants were 30.0 (SD = 8.0) years of age, had
9.4 (SD = 5.9) years of service, and had been deployed 1.7
(SD = 0.95) times. The average PCL-M total score was 26.93
(SD = 8.74); one participant had a score > 50 and was excluded
from the physiological analysis, 50 is a widely used cut-oﬀ for
identifying a likely diagnosis, while another two had a PCL-M
score within 5% of that cut-oﬀ. The frequency of PCL-M scores
are shown in a histogram (Figure 1). On average, epinephrine
levels increased by 2.2% after VR, whereas norepinephrine levels
decreased by 11.2%. Means and SD are shown in Table 1.
There were several signiﬁcant correlations among predictor
and outcome variables.When looking at the relationship between
PCL-M total score and outcomes, we found that higher PCL-
M scores were associated with more bodily pain (r = −0.37,
p < 0.01), and poorer general health (r = −0.24, p < 0.05),
mental health (r = −0.38, p < 0.01), emotional role functioning
(r = −0.24, p < 0.05), social functioning (r = −0.57, p < 0.01),
and vitality (r = −0.40, p < 0.01). When examining these corre-
lations on a symptom cluster level, higher levels of hyperarousal
was related to more bodily pain (r = 0.26, p < 0.05) and poorer
general health (r = −0.35, p < 0.01). There were no direct linear
FIGURE 1 | Frequency of PCL-M total scores.
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TABLE 1 | Means and SD for catecholamine, trauma symptoms, and
functioning scores.
Variable Mean (SD)
Baseline epinephrine 51.30 (25.57)
Epinephrine response 1.20 (36.13)
Baseline norepinephrine 274.77 (173.50)
Norepinephrine response −38.50 (200.30)
PCL-M total 26.93 (8.74)
PCL re-experiencing 7.22 (2.47)
PCL avoidance 8.92 (2.30)
PCL hyperarousal 8.76 (3.52)
Bodily pain 77.73 (16.93)
General health 82.32 (13.83)
Mental health 79.71 (11.38)
Physical functioning 94.69 (11.56)
Emotional role functioning 85.37 (27.27)
Physical role functioning 92.68 (16.89)
Social functioning 83.02 (17.17)
Vitality 63.90 (15.34)
PCL-M = Posttraumatic stress disorder (PTSD) checklist – military.
eﬀects observed between catecholamine responses and function-
ing status subscales.
Linear Regression
A series of simple and multiple linear regressions examined
the relationship between PCL-M symptom clusters and cate-
cholamine responses with functional status subscales. We used
a false discovery rate correction for multiple comparisons (q-
values) to determine signiﬁcance (i.e., p < 0.05 and q < 0.10).
First, we assessed whether PCL-M symptom clusters and cate-
cholamine responses were independently associated with func-
tional status subscales using several simple linear regressions. We
found a signiﬁcant main eﬀect for hyperarousal scores on general
health (β = −0.35, p = 0.001, q = 0.01), such that as hyper-
arousal increased, reported general health decreased. No other
main eﬀects were signiﬁcant. Next, we examined the independent
and interactive eﬀects of PCL-M symptom clusters and cate-
cholamine responses on functional status subscales using several
multiple linear regressions. Consistent with our hypothesis, nore-
pinephrine responses to VR combat sequences signiﬁcantly mod-
erated the relationship between avoidance and functional status
subscales, including physical functioning (β = 0.53, p < 0.001,
q = 0.001), physical role functioning (β = 0.36, p = 0.002,
q = 0.02), and vitality (β = 0.36, p = 0.002, q = 0.02; Figure 2).
For individuals with lower avoidance symptoms, increased nore-
pinephrine responses were associated with increased functional
status subscale scores, while participants with higher avoidance
symptoms, increased norepinephrine responses were associated
with decreased functional status subscale scores.
Discussion
Norepinephrine release in response to virtual combat sequences
modulates the relationship between the avoidance symptoms of
PTSD and multiple domains of functional status in a popula-
tion of recently deployed U.S. military SMs. For individuals with
lower levels of avoidance symptoms, a signiﬁcant catecholamine
response was indicative of better functional status. However, for
SMs reporting more severe avoidance symptoms, an ampliﬁed
catecholamine response was associated with poorer functional
status across multiple domains. From the perspective of emo-
tional processing theory, avoidance reduces opportunities to dis-
pel trauma-related, maladaptive beliefs, enabling the persistence
of hyperarousal and re-experiencing symptoms that may have
been normal initial reactions (Rauch and Foa, 2006). Participants
FIGURE 2 | Pattern of relationship between PCL-M avoidance and physical functioning, physical role functioning, and vitality as moderated by
norepinephrine response from baseline to post-virtual reality.
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having both higher avoidance symptoms and high catecholamine
responses to trauma-related stimuli may be disengaging from
day-to-day experiences, which may in turn adversely impact their
physical function, physical role function, and vitality. This pat-
tern of response may signal the diﬀerentiation between adaptive,
resilient coping responses and less adaptive responses that impact
functional status.
Our identiﬁcation of a link between PTSD symptom clus-
ters and functional status is consistent with a previous report
(Pietrzak et al., 2010), though our ﬁndings signiﬁcantly expand
upon the prior work both by examining the impact of psy-
chophysiological responses and by looking at a more broadly
representative population of SMs, all of whom fell below diag-
nostic criteria, as opposed to solely focusing on those meet-
ing diagnostic criteria for PTSD (Rauch and Foa, 2006). Our
ﬁndings complement previous studies that have shown that
combat-related VR engenders signiﬁcant psychophysiological
reactions among SMs (Kramer et al., 2013; Costanzo et al., 2014)
and decrease with treatment (Rothbaum et al., 2014), as well as
that catecholamines play an important role in PTSD and func-
tional status (Young and Breslau, 2004). Similar to more recent
work (Freeman et al., 2014), our ﬁndings also demonstrate the
assessment utility of VR in relation to PTSD. We are able to
expand signiﬁcantly upon the prior literature by exploring rela-
tionships between individual catecholamines, PTSD symptom
clusters, and various functional domains in a sample of SMwith a
wide range of symptom severity. We report that norepinephrine
modulates the relationship between avoidance and markers of
physical functioning (e.g., general physical functioning, phys-
ical role functioning, vitality). One previous report of a SM
with post-deployment PTSD documented greater epinephrine
and norepinephrine responses to combat sounds than was seen
in controls (Liberzon et al., 1999), which is not surprising, but
our study includes larger numbers and assesses the full spec-
trum of PTSD symptoms and reveals a far more nuanced pic-
ture. Our results support a role for VR in making such assess-
ments, with further studies needed in order to reﬁne its full
value.
In the present study, we included SM with a wide range of
traumatic symptoms. In doing so, we were able to capture a
population of SM who may already be engaging in resilient cop-
ing techniques, marked by their capacity to successfully adapt in
the face of stress and adversity (Jensen and Fraser, 2005). One
subset of our study population of particular interest is a group
that had low norepinephrine responses and relatively good func-
tional status despite relatively high avoidance scores. Whereas
resilience has more commonly been used to refer to those report-
ing relatively few symptoms after signiﬁcant trauma, it may
be that we are distinguishing another pattern of resilience in
this subset in which they acknowledge symptoms but are not
necessarily as troubled by them, either with regard to the auto-
nomic nervous system, or in terms of functional status. Although
PTSD had not been labeled as such at the time of World War
I or II, it is clear that there are many SMs, as well as such
groups as Holocaust survivors, who may have exhibited a similar
pattern, with sleep disruptions and other symptoms, yet they
were somehow able to function relatively well, and it would
certainly have been interesting to see what pattern their cat-
echolamine responses displayed. There are many avenues for
future research to investigate regarding resilience in a biopsy-
chosocial framework. Because kernels of resilience are embed-
ded within an individual prior to a trauma (Feder et al., 2009),
long-term prospective studies would be especially helpful to fur-
ther assess the trajectory of catecholamine levels in the face of
trauma. Such investigations could help to elucidate why one per-
son develops PTSD and another does not following a traumatic
experience.
There are several limitations inherent in our study. First, the
cross-sectional nature of the study does not allow us to draw
causal inferences. We cannot rule out common method vari-
ance that may result with the use of a single questionnaire, and
there may also be extraneous variables of signiﬁcance that were
not measured. Therefore, alternative explanations are plausible
(e.g., responses to PCL-M items may be inﬂuenced by salient
events and inﬂuence the reportable time-frame). Though our
ﬁndings require replication in other populations, our results rep-
resent a foundational step in utilizing catecholamine response to
VR combat scenarios in order to improve our understanding of
the relationship between PTSD symptom clusters and functional
status.
In recent years, VR has progressed from the realm of sci-
ence ﬁction to an accepted and proven method for deliver-
ing treatment for PTSD (Goncalves et al., 2012) and advances
in inexpensive hardware may soon make it a staple for video
gaming. VR has already been utilized to improve our under-
standing of prospective memory (Gonneaud et al., 2012), atten-
tional processes (Parsons and Rizzo, 2008), attention bias among
smokers (Marra et al., 2009), and food cravings (Ledoux et al.,
2013), and our work here is in keeping with such intellec-
tual explorations. We demonstrate that the measurement of
catecholamine responses to traumatic or stressful virtual pre-
sentations can enhance our understanding of PTSD symp-
tomatology, and what really matters most, how well someone
is functioning in the various domains of life. Translational
approaches to PTSD treatment focused on individual symp-
tom clusters hold promise (Norrholm and Jovanovic, 2010), and
we believe that elucidation of the signiﬁcance of the clus-
ters can be improved by exploring sympathetic nervous sys-
tem and consequent physiologic responses to VR. Our report
represents an early step on the path to improved understand-
ing and more individually tailored approaches to PTSD symp-
toms.
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